NEWS: HHS on human fetal tissue

Many vaccines contain fetal DNA, which poses ethical and health concerns. There are safer and more ethical options for manufacturers. Informed Choice WA hopes HHS’s announcement to review products containing fetal DNA includes all existing biological products, including vaccines.

HHS.gov

U.S. Department of Health & Human Services

FOR IMMEDIATE RELEASE

Contact: HHS Press Office September 24, 2018 202-690-6343 media@hhs.gov

Statement from the Department of Health and Human Services

“After a recent review of a contract between Advanced Bioscience Resources, Inc. and the Food and Drug Administration to provide human fetal tissue to develop testing protocols, HHS was not sufficiently assured that the contract included the appropriate protections applicable to fetal tissue research or met all other procurement requirements. As a result, that contract has been terminated, and HHS is now conducting an audit of all acquisitions involving human fetal tissue to ensure conformity with procurement and human fetal tissue research laws and regulations. In addition, HHS has initiated a comprehensive review of all research involving fetal tissue to ensure consistency with statutes and regulations governing such research, and to ensure the adequacy of procedures and oversight of this research in light of the serious regulatory, moral, and ethical considerations involved. Finally, HHS is continuing to review whether adequate alternatives exist to the use of human fetal tissue in HHS funded research and will ensure that efforts to develop such alternatives are funded and accelerated.”

###

page1image3830656

Note: All HHS press releases, fact sheets and other news materials are available at https://www.hhs.gov/news.

Print Friendly, PDF & Email